In this free webinar, the potential implications of Europe's joint clinical assessment (JCA)
process on pharmaceutical companies from a financial, R&D,
market access, regulatory, and operational perspective will be
discussed. Attendees will be introduced to the potential risks and
opportunities associated with the JCA, including strategies to
address these challenges and maximize potential benefits. The
featured speakers will discuss best practices for navigating the
complexities of the JCA to ensure successful submissions.
TORONTO, July 24,
2024 /PRNewswire-PRWeb/ -- Discover an informative
webinar that explores Europe's
highly anticipated JCA and its potentially profound impact on
the health technology assessment landscape.
While offering potential benefits such as
streamlined evaluations and accelerated market access, it also
brings forth a complex landscape of financial, regulatory, and
operational considerations for pharmaceutical companies.
The JCA presents a paradigm shift in the assessment of new
health technologies. While offering potential benefits such as
streamlined evaluations and accelerated market access, it also
brings forth a complex landscape of financial, regulatory, and
operational considerations for pharmaceutical companies.
This webinar will provide a comprehensive overview of the JCA
process, delving into its potential benefits, risks, and challenges
from multiple perspectives:
- Financial: Examine the financial implications of JCA, including
potential cost savings through reduced duplication of efforts and
the need for early investments in data generation and dossier
preparation
- Research & Development: Explore how JCA influences R&D
strategies, requiring early engagement with health technology
assessment (HTA) bodies and potentially impacting clinical trial
designs to meet specific data requirements
- Market Access: Discuss the potential for accelerated market
access across multiple European member states through a single
assessment and the continued importance of navigating individual
national reimbursement decisions
- Regulatory: Analyze the evolving regulatory landscape with JCA,
including the need for alignment with both European Medicines
Agency (EMA) requirements and the specific expectations of the JCA
process
- Operational: Address the operational complexities of JCA,
including resource allocation, coordination with multiple
stakeholders and the need for robust data management and
communication strategies
Register for this webinar today to gain insights into the
financial, regulatory and operational challenges and opportunities
that JCA presents for pharmaceutical companies.
Join experts from Anlitiks, Stephanie
Butler, PharmD, Principal Practice Lead; and Krithika
"Kitty" Rajagopalan, PhD, President & Chief Scientific Officer,
for the live webinar on Thursday, August 15,
2024, at 11am EDT
(4pm BST/UK).
For more information, or to register for this event, visit A
Navigating the Joint Clinical Assessment (JCA) Landscape: A
Strategic Roadmap for Pharmaceutical Companies.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading
provider of educational webinars and digital content to the global
life science, food, healthcare and medical device communities.
Every year, thousands of industry practitioners (from
pharmaceutical, biotechnology, food, healthcare and medical device
companies, private & academic research institutions, healthcare
centers, etc.) turn to Xtalks for access to quality content. Xtalks
helps professionals stay current with industry developments,
regulations and jobs. Xtalks webinars also provide perspectives on
key issues from top industry thought leaders and service
providers.
To learn more about Xtalks visit https://xtalks.com
For information about hosting a webinar visit
https://xtalks.com/why-host-a-webinar/
Media Contact
Soumya Shashikumar, Xtalks, +1
(416) 977-6555 x371, skumar@xtalks.com, https://xtalks.com
View original content to download
multimedia:https://www.prweb.com/releases/navigating-the-joint-clinical-assessment-jca-landscape-a-strategic-roadmap-for-pharmaceutical-companies-upcoming-webinar-hosted-by-xtalks-302204904.html
SOURCE Xtalks